HGV Status and Blood Component Exposure, AST Levels, and Times From Diagnosis and Treatment
| . | HGV Positive . | HGV Negative . | P Value . |
|---|---|---|---|
| . | (n = 29) . | (n = 31) . | . |
| Median time from diagnosis — years | 4.43 | 6.12 | .14 |
| (range) | (0.23-11.3) | (0.05-15.2) | |
| Median time from completion of treatment — years | 3.2 | 4.6 | .18 |
| (range) | (0-10.5) | (0-13.6) | |
| Median donor exposures | 130 | 95 | .48 |
| (range) | (20-685) | (17-483) | |
| Median red blood cell units | 37 | 25 | .12 |
| (range) | (3-96) | (4-88) | |
| Median platelet units | 78 | 84 | .79 |
| (range) | (9-610) | (0-412) | |
| Median concurrent AST level — U/L | 27 | 23 | .28 |
| (range) | (15-77) | (12-393) | |
| Median previous peak AST level — U/L | 72 | 82 | .68 |
| (range) | (17-427) | (13-777) |
| . | HGV Positive . | HGV Negative . | P Value . |
|---|---|---|---|
| . | (n = 29) . | (n = 31) . | . |
| Median time from diagnosis — years | 4.43 | 6.12 | .14 |
| (range) | (0.23-11.3) | (0.05-15.2) | |
| Median time from completion of treatment — years | 3.2 | 4.6 | .18 |
| (range) | (0-10.5) | (0-13.6) | |
| Median donor exposures | 130 | 95 | .48 |
| (range) | (20-685) | (17-483) | |
| Median red blood cell units | 37 | 25 | .12 |
| (range) | (3-96) | (4-88) | |
| Median platelet units | 78 | 84 | .79 |
| (range) | (9-610) | (0-412) | |
| Median concurrent AST level — U/L | 27 | 23 | .28 |
| (range) | (15-77) | (12-393) | |
| Median previous peak AST level — U/L | 72 | 82 | .68 |
| (range) | (17-427) | (13-777) |
Abbreviations: HGV, hepatitis G virus; AST, aspartate aminotransferase.